NEURODEGENERATION NEWS ++++

NEURODEGENERATION NEWS Alzheimer’s Agitation Drug Still Promising Novel Agent for Alzheimer’s Agitation Continues to Show Promise Megan Brooks April 11, 2025 https://www.medscape.com/viewarticle/novel-agent-alzheimers-agitation-continues-show-promise-2025a10008os?ecd=WNL_conf_neuro_AAN-SPON_250426_MSCPEDIT_etid7377172&uac=148436CN&impID=7377172 Drug Slows Huntington’s in Early Stages Investigational Drug Slows Decline in Early Huntington Pauline Anderson April 14, 2025 https://www.medscape.com/viewarticle/investigational-drug-slows-decline-early-huntington-2025a10008s2?ecd=WNL_conf_neuro_AAN-SPON_250426_MSCPEDIT_etid7377172&uac=148436CN&impID=7377172 Wearable Device Calms Essential Tremor AI-Powered Wearable Calms Essential Tremor Megan Brooks April 10, 2025 https://www.medscape.com/viewarticle/ai-powered-wearable-calms-essential-tremor-2025a10008kp?ecd=WNL_conf_neuro_AAN-SPON_250426_MSCPEDIT_etid7377172&uac=148436CN&impID=7377172 Inebilizumab Safe Long-Term in MG Inebilizumab Safe, Effective Up to 52 Weeks in Myasthenia Gravis Deborah Brauser April 10, 2025 https://www.medscape.com/viewarticle/inebilizumab-safe-effective-52-weeks-myasthenia-gravis-2025a10008kk?ecd=WNL_conf_neuro_AAN-SPON_250426_MSCPEDIT_etid7377172&uac=148436CN&impID=7377172